Overview

 

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment ACTH(4–7), modified with a Pro-Gly-Pro sequence to enhance stability. Research has focused on its effects on neuroprotection, cognitive function, neuroplasticity, neurotransmitter regulation, learning, memory, and recovery following neurological injury. Semax has been extensively investigated in neuroscience and neuroregeneration research.

Mechanism of Action

Research suggests Semax influences multiple neurobiological pathways, including modulation of BDNF (Brain-Derived Neurotrophic Factor), neurotransmitter signaling, neuroplasticity, and gene expression. Studies indicate it may affect dopaminergic, serotonergic, and neurotrophic systems while supporting neuronal adaptation and recovery processes. Increased BDNF expression has been observed following Semax administration in experimental models.

Compound Information

Stability Information

Information provided for educational and research reference purposes only. Studies listed are third-party publications and do not constitute medical advice.